{"title":"Association of stroke and mortality among patients receiving heart transplantation-a nationwide study.","authors":"Wei-Syun Hu, Cheng-Li Lin","doi":"10.1007/s00210-025-04026-w","DOIUrl":null,"url":null,"abstract":"<p><p>This study aims to define the association of heart transplantation with incident stroke, cardiovascular (CV) and all-cause death. The incidence rate (IR) was calculated by dividing the number of outcomes by the summed person-years in the group during the follow-up period. Crude and adjusted hazard ratios (HRs) and the corresponding 95% confidence intervals (CIs) were estimated through univariable and multivariable Cox proportional hazards models. Propensity score (PS) matching analysis was adopted to minimize the differences between the two cohorts. Each cohort had 13,948 study participants. Compared to the control group, patients with heart transplantation had a higher risk of stroke (adjusted HR [95% CI] = 2.96 [2.72, 3.22]) and CV death (adjusted HR [95% CI] = 5.33 [4.87, 5.83]), and the risk is higher in the subgroup of the male sex, without comorbidity, and follow-up period < 10 years. Among patients who underwent cardiac transplantation, the subgroups of the male sex, without comorbidities and short follow-up period are at higher risk for incident stroke and CV death.</p>","PeriodicalId":18876,"journal":{"name":"Naunyn-Schmiedeberg's archives of pharmacology","volume":" ","pages":""},"PeriodicalIF":3.1000,"publicationDate":"2025-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Naunyn-Schmiedeberg's archives of pharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00210-025-04026-w","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
This study aims to define the association of heart transplantation with incident stroke, cardiovascular (CV) and all-cause death. The incidence rate (IR) was calculated by dividing the number of outcomes by the summed person-years in the group during the follow-up period. Crude and adjusted hazard ratios (HRs) and the corresponding 95% confidence intervals (CIs) were estimated through univariable and multivariable Cox proportional hazards models. Propensity score (PS) matching analysis was adopted to minimize the differences between the two cohorts. Each cohort had 13,948 study participants. Compared to the control group, patients with heart transplantation had a higher risk of stroke (adjusted HR [95% CI] = 2.96 [2.72, 3.22]) and CV death (adjusted HR [95% CI] = 5.33 [4.87, 5.83]), and the risk is higher in the subgroup of the male sex, without comorbidity, and follow-up period < 10 years. Among patients who underwent cardiac transplantation, the subgroups of the male sex, without comorbidities and short follow-up period are at higher risk for incident stroke and CV death.
期刊介绍:
Naunyn-Schmiedeberg''s Archives of Pharmacology was founded in 1873 by B. Naunyn, O. Schmiedeberg and E. Klebs as Archiv für experimentelle Pathologie und Pharmakologie, is the offical journal of the German Society of Experimental and Clinical Pharmacology and Toxicology (Deutsche Gesellschaft für experimentelle und klinische Pharmakologie und Toxikologie, DGPT) and the Sphingolipid Club. The journal publishes invited reviews, original articles, short communications and meeting reports and appears monthly. Naunyn-Schmiedeberg''s Archives of Pharmacology welcomes manuscripts for consideration of publication that report new and significant information on drug action and toxicity of chemical compounds. Thus, its scope covers all fields of experimental and clinical pharmacology as well as toxicology and includes studies in the fields of neuropharmacology and cardiovascular pharmacology as well as those describing drug actions at the cellular, biochemical and molecular levels. Moreover, submission of clinical trials with healthy volunteers or patients is encouraged. Short communications provide a means for rapid publication of significant findings of current interest that represent a conceptual advance in the field.